As an example, in early-stage non-small cell lung cancer (NSCLC), the utility of neuron-specific enolase (NSE), CA125, and squamous cell carcinoma antigen (SCC) was found to be limited, even when these three markers were used in combination (12). This evidence concerns the gene ENO2 and non-small cell lung carcinoma.